iBio legal chief increases stake with $23,055 purchase as pipeline news draws analyst attention
iBio Chief Legal Officer Marc Banjak acquired 13,934 shares of common stock on March 26, 2026, spending $23,055 across two transactions. The purchases come amid recent stock volatility, upbeat preclinical results for the company’s obesity candidate IBIO-610, analyst Buy ratings and a strong reported current ratio despite a modest market capitalizat…